Search Results
372 results
Your search is now limited to «Diabetes Clinical Trials» expert search.
American Diabetes Journals 03/20/2019 15:00
Rapid progress has been made in testing closed-loop delivery systems during unrestricted living in randomized clinical trials across a broad range of people with type 1 diabetes (6–10.
More from American Diabetes Journals:
FeedNavigator 03/20/2019 10:30
For instance, as periodontitis acts within the same chronic inflammatory model seen in cardiovascular disease (CVD), or other disorders, such as diabetes, several studies have suggested the existence of a bi-directional link between periodontal health and these pathologies.
More from FeedNavigator:
PR Newswire 03/20/2019 10:08
The efficacy and safety of oral semaglutide was evaluated in 10 PIONEER clinical trials, which included 9,543 adults with type 2 diabetes.
More from PR Newswire:
Approval was based on a comprehensive global Phase III clinical trial programme.2 About VOKANAMET Vokanamet (a fixed-dose combination of canagliflozin and metformin) is approved in the European Union for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an ...
More from Global Banking & Finance Review:
Korean Biomedical Review 03/19/2019 05:48
Also, the results of phase 3 ONSET studies evaluated the efficacy and safety of Fiasp on 689 patients with type 2 diabetes, while the results from the ONSET 2 study showed blood glucose control effect to be comparable to insulin aspart as well as a significant improvement in post-meal blood glucose ...
More from Korean Biomedical Review:
Medindia.com 03/19/2019 01:14
In male mice, swapping dietary saturated fats for monounsaturated fats reversed nerve damage and restored nerve function, reveals new preclinical research published in JNeurosci.
More from Medindia.com:
Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip.
More from International Journal of COPD:
WN.com 03/18/2019 19:48
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
More from WN.com:
Healio News 03/18/2019 16:02
In the overall DECLARE-TIMI 58 CV outcome trial, dapagliflozin 10 mg (Farxiga, AstraZeneca) reduced the composite endpoint of CV death and HF hospitalization over 4 years — mainly driven by the reduction in HF hospitalization — in a broad population of patients with type 2 diabetes ...
More from Healio News:
GlobeNewswire 03/18/2019 12:00
Resverlogix also advances its Fabry Disease indication data and planning. Resverlogix also advances its Fabry Disease indication data and planning.
More from GlobeNewswire:
ClinicalTrials.gov 03/18/2019 10:46
Interestingly, other research has shown that bile acids may help patients with neurological disease and diabetes.
More from ClinicalTrials.gov:
Business Wire 03/18/2019 09:01
DECLARE is paving the way for three Phase III trials: Dapa-HF, DELIVER and Dapa-CKD.
More from Business Wire:
ENDPOINTS 03/18/2019 08:46
Roughly two years after raising $40 million in a private placement, Aerpio Pharmaceuticals’ lead experimental eye drug has hit a roadblock after failing a mid-stage study in patients with non-proliferative diabetic retinopathy (NPDR) — the earliest stage of diabetic eye disease, which occurs when high blood sugar levels cause damage to blood vessels in the retina.
More from ENDPOINTS:
Benzinga 03/16/2019 08:35
Biotech stocks had an upweek, with the release of clinical trial results and the positive broader market sentiment offering ample support.
More from Benzinga:
News-Medical.net 03/13/2019 05:04
For one of the studies, researchers looked at 264 patients who were enrolled in the FACTOR-64 study, which was a clinical trial designed to reduce the risks of diabetic patients for cardiovascular disease.
More from News-Medical.net:
Notice NOT-DK-19-011 from the NIH Guide for Grants and Contracts.
More from National Institutes of Health (NIH):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications